4.7 Review

Pertussis and influenza immunisation during pregnancy: a landscape review

Journal

LANCET INFECTIOUS DISEASES
Volume 17, Issue 7, Pages E209-E222

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/S1473-3099(17)30190-1

Keywords

-

Funding

  1. Sanofi Pasteur
  2. GlaxoSmithKline
  3. Bill & Melinda Gates Foundation
  4. Novartis

Ask authors/readers for more resources

Immunisation during pregnancy is a relatively new strategy, and is currently limited to tetanus, pertussis, and influenza vaccines. None of these vaccines were developed specifically for use in pregnancy, but they provide an effective method of protecting mothers and young infants. In response to increases in pertussis morbidity and mortality among young infants, several countries have recommended universal tetanus, diphtheria, and acellular pertussis immunisation during pregnancy. Similarly, many countries recommend influenza immunisation during pregnancy to reduce the risk of disease for mother and infant. Although scientific evidence to support maternal immunisation against pertussis and influenza is rapidly accumulating, important knowledge gaps remain that need to be addressed by future research, which we have highlighted in this Series paper.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available